295 related articles for article (PubMed ID: 21483568)
1. Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement.
Taher YA; Henricks PA; van Oosterhout AJ
Libyan J Med; 2010 Jun; 5():. PubMed ID: 21483568
[TBL] [Abstract][Full Text] [Related]
2. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
3. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
[TBL] [Abstract][Full Text] [Related]
4. Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy.
Maazi H; Shirinbak S; Willart M; Hammad HM; Cabanski M; Boon L; Ganesh V; Baru AM; Hansen G; Lambrecht BN; Sparwasser T; Nawijn MC; van Oosterhout AJ
Clin Exp Allergy; 2012 Oct; 42(10):1519-28. PubMed ID: 22994349
[TBL] [Abstract][Full Text] [Related]
5. Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy.
Jacobsen L; Wahn U; Bilo MB
Clin Transl Allergy; 2012 Apr; 2():8. PubMed ID: 22500494
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of IL-4/IL-13 does not enhance the efficacy of allergen immunotherapy in murine allergic airway inflammation.
Gogishvili T; Hahn C; Meinhard J; Hohaus A; Erb K; Sebald W; Bröcker EB; Grunewald SM
Int Arch Allergy Immunol; 2007; 142(2):165-74. PubMed ID: 17077644
[TBL] [Abstract][Full Text] [Related]
8. Modulation of regulatory T cells by intranasal allergen immunotherapy in an experimental rat model of airway allergy.
Moitra S; Datta A; Mondal S; Hazra I; Faruk SMO; Das PK; Basu AK; Tripathi SK; Chaudhuri S
Int Immunopharmacol; 2017 Jun; 47():9-19. PubMed ID: 28349869
[TBL] [Abstract][Full Text] [Related]
9. T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease.
Rolland JM; Prickett S; Gardner LM; O'Hehir RE
Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):201-22. PubMed ID: 23597085
[TBL] [Abstract][Full Text] [Related]
10. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis.
Stock P; Rolinck-Werninghaus C; Wahn U; Hamelmann E
BioDrugs; 2007; 21(6):403-10. PubMed ID: 18020623
[TBL] [Abstract][Full Text] [Related]
11. Three-year follow-up study of allergen-induced in vitro cytokine and signalling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy.
Nieminen K; Laaksonen K; Savolainen J
Int Arch Allergy Immunol; 2009; 150(4):370-6. PubMed ID: 19571569
[TBL] [Abstract][Full Text] [Related]
12. Does allergen immunotherapy alter the natural course of allergic disorders?
Yang X
Drugs; 2001; 61(3):365-74. PubMed ID: 11293647
[TBL] [Abstract][Full Text] [Related]
13. Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma.
Janssen EM; Wauben MH; Jonker EH; Hofman G; Van Eden W; Nijkamp FP; Van Oosterhout AJ
Am J Respir Cell Mol Biol; 1999 Jul; 21(1):21-9. PubMed ID: 10385589
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in allergen immunotherapy.
Nouri-Aria KT
Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
[TBL] [Abstract][Full Text] [Related]
16. 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta.
Taher YA; van Esch BC; Hofman GA; Henricks PA; van Oosterhout AJ
J Immunol; 2008 Apr; 180(8):5211-21. PubMed ID: 18390702
[TBL] [Abstract][Full Text] [Related]
17. Role of IL-4 receptor α-positive CD4(+) T cells in chronic airway hyperresponsiveness.
Kirstein F; Nieuwenhuizen NE; Jayakumar J; Horsnell WGC; Brombacher F
J Allergy Clin Immunol; 2016 Jun; 137(6):1852-1862.e9. PubMed ID: 26688514
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
[TBL] [Abstract][Full Text] [Related]
19. [The immunological mechanisms contributing to the clinical efficacy of allergen specific immunotherapy (SIT) in allergic diseases].
Asher I; Mahlab-Guri K; Sthoeger Z
Harefuah; 2013 Sep; 152(9):529-33, 564, 563. PubMed ID: 24364093
[TBL] [Abstract][Full Text] [Related]
20. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
